Cargando…

Molecular Epidemiology of Multi-Drug Resistant Pseudomonas aeruginosa Isolates from Hospitalized Patients in Greece

Resistant Pseudomonas aeruginosa isolates are one of the major causes of both hospital-acquired infections (HAIs) and community-acquired infections (CAIs). However, management of P. aeruginosa infections is difficult as the bacterium is inherently resistant to many antibiotics. In this study, a coll...

Descripción completa

Detalles Bibliográficos
Autores principales: Pappa, Olga, Kefala, Anastasia Maria, Tryfinopoulou, Kyriaki, Dimitriou, Marios, Kostoulas, Kostas, Dioli, Chrysa, Moraitou, Eleni, Panopoulou, Maria, Vogiatzakis, Evaggelos, Mavridou, Athena, Galanis, Alex, Beloukas, Apostolos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693957/
https://www.ncbi.nlm.nih.gov/pubmed/33114400
http://dx.doi.org/10.3390/microorganisms8111652
_version_ 1783614865883004928
author Pappa, Olga
Kefala, Anastasia Maria
Tryfinopoulou, Kyriaki
Dimitriou, Marios
Kostoulas, Kostas
Dioli, Chrysa
Moraitou, Eleni
Panopoulou, Maria
Vogiatzakis, Evaggelos
Mavridou, Athena
Galanis, Alex
Beloukas, Apostolos
author_facet Pappa, Olga
Kefala, Anastasia Maria
Tryfinopoulou, Kyriaki
Dimitriou, Marios
Kostoulas, Kostas
Dioli, Chrysa
Moraitou, Eleni
Panopoulou, Maria
Vogiatzakis, Evaggelos
Mavridou, Athena
Galanis, Alex
Beloukas, Apostolos
author_sort Pappa, Olga
collection PubMed
description Resistant Pseudomonas aeruginosa isolates are one of the major causes of both hospital-acquired infections (HAIs) and community-acquired infections (CAIs). However, management of P. aeruginosa infections is difficult as the bacterium is inherently resistant to many antibiotics. In this study, a collection of 75 P. aeruginosa clinical isolates from two tertiary hospitals from Athens and Alexnadroupolis in Greece was studied to assess antimicrobial sensitivity and molecular epidemiology. All P. aeruginosa isolates were tested for susceptibility to 11 commonly used antibiotics, and the newly introduced Double Locus Sequence Typing (DLST) scheme was implemented to elucidate the predominant clones. The tested P. aeruginosa isolates presented various resistant phenotypes, with Verona Integron-Mediated Metallo-β-lactamase (VIM-2) mechanisms being the majority, and a new phenotype, FEP(R)-CAZ(S,) being reported for the first time in Greek isolates. DLST revealed two predominant types, 32-39 and 8-37, and provided evidence for intra-hospital transmission of the 32-39 clone in one of the hospitals. The results indicate that DLST can be a valuable tool when local outbreaks demand immediate tracking investigation with limited time and financial resources.
format Online
Article
Text
id pubmed-7693957
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76939572020-11-28 Molecular Epidemiology of Multi-Drug Resistant Pseudomonas aeruginosa Isolates from Hospitalized Patients in Greece Pappa, Olga Kefala, Anastasia Maria Tryfinopoulou, Kyriaki Dimitriou, Marios Kostoulas, Kostas Dioli, Chrysa Moraitou, Eleni Panopoulou, Maria Vogiatzakis, Evaggelos Mavridou, Athena Galanis, Alex Beloukas, Apostolos Microorganisms Article Resistant Pseudomonas aeruginosa isolates are one of the major causes of both hospital-acquired infections (HAIs) and community-acquired infections (CAIs). However, management of P. aeruginosa infections is difficult as the bacterium is inherently resistant to many antibiotics. In this study, a collection of 75 P. aeruginosa clinical isolates from two tertiary hospitals from Athens and Alexnadroupolis in Greece was studied to assess antimicrobial sensitivity and molecular epidemiology. All P. aeruginosa isolates were tested for susceptibility to 11 commonly used antibiotics, and the newly introduced Double Locus Sequence Typing (DLST) scheme was implemented to elucidate the predominant clones. The tested P. aeruginosa isolates presented various resistant phenotypes, with Verona Integron-Mediated Metallo-β-lactamase (VIM-2) mechanisms being the majority, and a new phenotype, FEP(R)-CAZ(S,) being reported for the first time in Greek isolates. DLST revealed two predominant types, 32-39 and 8-37, and provided evidence for intra-hospital transmission of the 32-39 clone in one of the hospitals. The results indicate that DLST can be a valuable tool when local outbreaks demand immediate tracking investigation with limited time and financial resources. MDPI 2020-10-24 /pmc/articles/PMC7693957/ /pubmed/33114400 http://dx.doi.org/10.3390/microorganisms8111652 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pappa, Olga
Kefala, Anastasia Maria
Tryfinopoulou, Kyriaki
Dimitriou, Marios
Kostoulas, Kostas
Dioli, Chrysa
Moraitou, Eleni
Panopoulou, Maria
Vogiatzakis, Evaggelos
Mavridou, Athena
Galanis, Alex
Beloukas, Apostolos
Molecular Epidemiology of Multi-Drug Resistant Pseudomonas aeruginosa Isolates from Hospitalized Patients in Greece
title Molecular Epidemiology of Multi-Drug Resistant Pseudomonas aeruginosa Isolates from Hospitalized Patients in Greece
title_full Molecular Epidemiology of Multi-Drug Resistant Pseudomonas aeruginosa Isolates from Hospitalized Patients in Greece
title_fullStr Molecular Epidemiology of Multi-Drug Resistant Pseudomonas aeruginosa Isolates from Hospitalized Patients in Greece
title_full_unstemmed Molecular Epidemiology of Multi-Drug Resistant Pseudomonas aeruginosa Isolates from Hospitalized Patients in Greece
title_short Molecular Epidemiology of Multi-Drug Resistant Pseudomonas aeruginosa Isolates from Hospitalized Patients in Greece
title_sort molecular epidemiology of multi-drug resistant pseudomonas aeruginosa isolates from hospitalized patients in greece
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693957/
https://www.ncbi.nlm.nih.gov/pubmed/33114400
http://dx.doi.org/10.3390/microorganisms8111652
work_keys_str_mv AT pappaolga molecularepidemiologyofmultidrugresistantpseudomonasaeruginosaisolatesfromhospitalizedpatientsingreece
AT kefalaanastasiamaria molecularepidemiologyofmultidrugresistantpseudomonasaeruginosaisolatesfromhospitalizedpatientsingreece
AT tryfinopouloukyriaki molecularepidemiologyofmultidrugresistantpseudomonasaeruginosaisolatesfromhospitalizedpatientsingreece
AT dimitrioumarios molecularepidemiologyofmultidrugresistantpseudomonasaeruginosaisolatesfromhospitalizedpatientsingreece
AT kostoulaskostas molecularepidemiologyofmultidrugresistantpseudomonasaeruginosaisolatesfromhospitalizedpatientsingreece
AT diolichrysa molecularepidemiologyofmultidrugresistantpseudomonasaeruginosaisolatesfromhospitalizedpatientsingreece
AT moraitoueleni molecularepidemiologyofmultidrugresistantpseudomonasaeruginosaisolatesfromhospitalizedpatientsingreece
AT panopouloumaria molecularepidemiologyofmultidrugresistantpseudomonasaeruginosaisolatesfromhospitalizedpatientsingreece
AT vogiatzakisevaggelos molecularepidemiologyofmultidrugresistantpseudomonasaeruginosaisolatesfromhospitalizedpatientsingreece
AT mavridouathena molecularepidemiologyofmultidrugresistantpseudomonasaeruginosaisolatesfromhospitalizedpatientsingreece
AT galanisalex molecularepidemiologyofmultidrugresistantpseudomonasaeruginosaisolatesfromhospitalizedpatientsingreece
AT beloukasapostolos molecularepidemiologyofmultidrugresistantpseudomonasaeruginosaisolatesfromhospitalizedpatientsingreece